Inflammation has become a hot topic in many research labs across the globe. A recent article published in 2015 called The role of inflammation in depression: from evolutionary imperative to modern treatment target looked at the biological connection between depression and the immune system. Scientists are now trying to develop a medical test for the detection of inflammation in depressed patients. Many individuals are completely clueless when it comes to this "Silent Killer." In fact many believe that inflammation in general is a great thing to have. Which it is... but not chronically.
Dr. Eric Pietras from the University of Colorado Cancer Center is currently investigating the potential harmful effects of chronic inflammation on hematopoietic stem cells. Dr. Pietras states, "They're (HSC's) receiving a signal telling them they need to keep building myeloid cells and as a result they don't make the other blood cells you need. You can end up with too few red blood cells, reducing the body's ability to deliver oxygen to cells. Or we see decreased production of new lymphoid cells, leaving the system potentially immunodeficient. These are all common features of chronically inflamed and even aged blood systems."
This is why the use of systemic enzymes has been shown to be beneficial for many individuals suffering from chronic inflammation. CRP levels, which are proteins released by the liver in response to inflammation, have been experimentally shown to decrease with the use of Serrapeptase and Nattokinase. Enzyme therapy over the years has helped millions overcome their struggle with inflammation.
Eric M. Pietras, Cristina Mirantes-Barbeito, Sarah Fong, Dirk Loeffler, Larisa V. Kovtonyuk, SiYi Zhang, Ranjani Lakshminarasimhan, Chih Peng Chin, José-Marc Techner, Britta Will, Claus Nerlov, Ulrich Steidl, Markus G. Manz, Timm Schroeder, Emmanuelle Passegué. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nature Cell Biology, 2016; DOI: 10.1038/ncb3346
Dr. Eric Pietras from the University of Colorado Cancer Center is currently investigating the potential harmful effects of chronic inflammation on hematopoietic stem cells. Dr. Pietras states, "They're (HSC's) receiving a signal telling them they need to keep building myeloid cells and as a result they don't make the other blood cells you need. You can end up with too few red blood cells, reducing the body's ability to deliver oxygen to cells. Or we see decreased production of new lymphoid cells, leaving the system potentially immunodeficient. These are all common features of chronically inflamed and even aged blood systems."
This is why the use of systemic enzymes has been shown to be beneficial for many individuals suffering from chronic inflammation. CRP levels, which are proteins released by the liver in response to inflammation, have been experimentally shown to decrease with the use of Serrapeptase and Nattokinase. Enzyme therapy over the years has helped millions overcome their struggle with inflammation.
Eric M. Pietras, Cristina Mirantes-Barbeito, Sarah Fong, Dirk Loeffler, Larisa V. Kovtonyuk, SiYi Zhang, Ranjani Lakshminarasimhan, Chih Peng Chin, José-Marc Techner, Britta Will, Claus Nerlov, Ulrich Steidl, Markus G. Manz, Timm Schroeder, Emmanuelle Passegué. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nature Cell Biology, 2016; DOI: 10.1038/ncb3346